Related Experiment Video
Updated: Apr 15, 2026

Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
Stress, metabolism and cancer: integrated pathways contributing to immune suppression
Elizabeth A Repasky1, Jason Eng, Bonnie L Hylander
1From the Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY.
Abstract:
The potential for immune cells to control cancers has been recognized for many decades, but only recently has real excitement begun to spread through the oncology community following clear evidence that therapeutic blockade of specific immune-suppressive mechanisms is enough to make a real difference in survival for patients with several different advanced cancers. However, impressive and encouraging as these new clinical data are, it is clear that more effort should be devoted toward understanding the full spectrum of factors within cancer patients, which have the potential to block or weaken antitumor activity by immune cells. The goal of this brief review is to highlight recent literature revealing interactive stress and metabolic pathways, particularly those mediated by the sympathetic nervous system, which may conspire to block immune cells from unleashing their full killing potential. There is exciting new information regarding the role of neurogenesis by tumors and adrenergic signaling in cancer progression (including metabolic changes associated with cachexia and lipolysis) and in regulation of immune cell function and differentiation. However, much more work is needed to fully understand how the systemic metabolic effects mediated by the brain and nervous system can be targeted for therapeutic efficacy in the setting of immunotherapy and other cancer therapies.
Insights
The sympathetic nervous system and stress pathways can suppress immune cells, hindering cancer control. Targeting these pathways may improve immunotherapy effectiveness for cancer patients.
Area of Science:
- Oncology
- Immunology
- Neuroscience
Background:
- Immune cells show potential for cancer control.
- Recent advances in immunotherapy demonstrate improved survival in advanced cancers by blocking immune suppression.
- Further research is needed to understand factors that inhibit anti-tumor immune activity.
Purpose of the Study:
- To review literature on stress and metabolic pathways, particularly those involving the sympathetic nervous system, that impede immune cell anti-tumor activity.
- To highlight the role of neurogenesis and adrenergic signaling in cancer progression and immune regulation.
- To underscore the need for further investigation into targeting systemic metabolic effects for enhanced cancer therapy.
Main Methods:
- Literature review of recent studies.
- Focus on interactive stress and metabolic pathways.
- Examination of sympathetic nervous system influence on immune cells.
Main Results:
- Sympathetic nervous system and stress pathways can suppress immune cell function.
- Tumor neurogenesis and adrenergic signaling impact cancer progression, cachexia, and lipolysis.
- These pathways influence immune cell differentiation and function.
Conclusions:
- The sympathetic nervous system plays a significant role in modulating the immune response to cancer.
- Understanding and targeting neuro-metabolic pathways is crucial for improving cancer immunotherapy.
- More research is required to fully leverage these systemic effects for therapeutic benefit.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The Tumor Microenvironment